AstraZeneca contacted Gilead last month and it did not provide the terms of any transaction, the report https://bloom.bg/3h2GU9e added. A spokeswoman for AstraZeneca said the company does comment on rumours or speculation. Gilead did not immediately respond to a request for comment. …read more
Source:: Yahoo Finance
